Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Targinact 10 mg/5 mg prolonged-release tablets

Active Ingredient:
naloxone hydrochloride dihydrate , oxycodone hydrochloride
Company:  
Napp Pharmaceuticals Limited See contact details
ATC code: 
N02AA55
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 24 Apr 2025
{pdf} View or print the patient leaflet as PDF
Napp Pharmaceuticals Limited
Company image
Address
Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0GW
Telephone
+44 (0)1223 424 444
WWW
http://www.napp.co.uk
Medical Information e-mail
[email protected]